SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-056629
Filing Date
2018-11-01
Accepted
2018-11-01 08:01:12
Documents
38
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv505529_10q.htm 10-Q 225710
2 EXHIBIT 31.1 tv505529_ex31-1.htm EX-31.1 8187
3 EXHIBIT 31.2 tv505529_ex31-2.htm EX-31.2 8238
4 EXHIBIT 32.1 tv505529_ex32-1.htm EX-32.1 3528
  Complete submission text file 0001144204-18-056629.txt   4303593

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT gnmx-20180930.xml EX-101.INS 1565757
6 XBRL TAXONOMY EXTENSION SCHEMA gnmx-20180930.xsd EX-101.SCH 33609
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gnmx-20180930_cal.xml EX-101.CAL 17384
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnmx-20180930_def.xml EX-101.DEF 156520
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnmx-20180930_lab.xml EX-101.LAB 191294
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnmx-20180930_pre.xml EX-101.PRE 171686
Mailing Address 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087
Business Address 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087 610-254-4201
Aevi Genomic Medicine, Inc. (Filer) CIK: 0001138776 (see all company filings)

IRS No.: 980217544 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35112 | Film No.: 181152068
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1